{"id":55896,"date":"2022-04-25T09:12:02","date_gmt":"2022-04-25T07:12:02","guid":{"rendered":"https:\/\/drgonzalezcantero.com\/american-academy-dermatology-2022\/"},"modified":"2026-09-02T09:48:56","modified_gmt":"2026-09-02T07:48:56","slug":"american-academy-dermatology-2022","status":"publish","type":"post","link":"https:\/\/drgonzalezcantero.com\/en\/american-academy-dermatology-2022\/","title":{"rendered":"Presentation at the American Academy of Dermatology Annual Meeting (2022)"},"content":{"rendered":"\n

Presentation on psoriasis and comorbidities at the 2022 Annual Meeting of the American Academy of Dermatology<\/em>, held in Boston.<\/p>\n\n

Last March, I had the honour of being invited by the American Academy of Dermatology to present our research projects on psoriasis and its associated comorbidities, focusing particularly on the relationship between psoriasis and cardiovascular disease<\/strong>.<\/p>\n\n

Some of the key<\/strong> conclusions from the topics discussed were:<\/p>\n\n

\u2022 Myocardial infarction is one of the leading causes of death worldwide, and atherosclerosis<\/a> is a major underlying cause.<\/p>\n\n

\u2022 We know that inflammation can accelerate atherosclerosis, and psoriasis is a chronic inflammatory disease.<\/p>\n\n

\u2022 Patients with psoriasis have an increased risk of cardiovascular disease compared with the general population.<\/p>\n\n

\u2022 We have imaging techniques that can help detect atherosclerotic plaques at an early stage.<\/p>\n\n

\u2022 It is important to discuss this information with patients with psoriasis and to adopt appropriate measures both in terms of medical treatment and lifestyle \u2014 to reduce cardiovascular risk.<\/p>\n\n

Further information (in English):<\/p>\n\n

\u2022 Interview<\/a> with The Dermatologist (podcast).<\/p>\n\n